(VIANEWS) - Performance Shipping (PSHG), Genmab (GMAB), Jiayin Group (JFIN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Performance Shipping (PSHG)
313.8% sales growth and 9.63% return on equity
Performance Shipping Inc., through its subsidiaries, provides shipping transportation services through its ownership of tanker vessels worldwide. It owned and operated five Aframax tanker vessels with a combined carrying capacity of 546,094 dwt. The company was incorporated in 2010 and is based in Athens, Greece.
Earnings Per Share
As for profitability, Performance Shipping has a trailing twelve months EPS of $-1.931.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.63%.Revenue Growth
Year-on-year quarterly revenue growth grew by 137.2%, now sitting on 57.05M for the twelve trailing months.
2. Genmab (GMAB)
31.8% sales growth and 17.71% return on equity
Genmab A/S is a Danish company that develops and markets antibody therapies for cancer treatment. DARZALEX is a monoclonal human antibody that can be used to treat multiple myeloma. Teprotumumab is for treatment of thyroid disease. Ofatumurnab (a human monoclonal anti-body for chronic lymphocyticleukemia (CLL), multiple sclerosis) and Amivantamab (for advanced, metastatic, or esophageal, cancers and NSCLC) are also available. Daratumumab is used to treat MM and non-MM blood tumors and AL Amyloidosis. There are also products being developed by the company. Phase 2 includes Teclistamab to treat vaso-occlusive crisis; Camidanlumab tesirine for treatment of hodgkin lymphoma; JNJ-64407564 for treatment of MM; PRV-015 to treat celiac disorder; Mim8 to treat haemophilia; and Lu AF82422 to treat multiple system atrophy. It also has 20 preclinical trials. Seagen Inc. has granted the company a collaboration and commercial license to develop tisotumab. The company also has a partnership agreement with CureVac AG to research and develop differentiated mRNA-based antibodies products. AbbVie is responsible for developing epcoritamab. There are collaborations with BioNTech, Janssen, Novo Nordisk A/S, Bolt Biotherapeutics, Inc. Genmab A/S was established in 1999. Its headquarters are in Copenhagen, Denmark.
Earnings per Share
Genmab's trailing 12 months profit per share is $0.66
PE Ratio
Genmab's trailing 12-month price-earnings ratio is 65.12. The purchaser of the shares is therefore investing $65.12 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 17.71%.Annual Top and Bottom Value
Genmab stock was valued at $43.05 as of 15:22 EST. This is below the 52-week high at $47.50, and well above its 52 week low at $26.19.
3. Jiayin Group (JFIN)
26.3% sales growth and 259.74% return on equity
Jiayin Group Inc. operates as an online individual finance platform that connects individual investors and individual borrowers in China. It operates a secure and open platform that facilitates transparent, secure, and fast connections between investors and borrowers. The company was founded in 2011 and is based in Shanghai, the People's Republic of China.
Earnings Per Share
As for profitability, Jiayin Group has a trailing twelve months EPS of $2.06.
PE Ratio
Jiayin Group has a trailing twelve months price to earnings ratio of 1.02. Meaning, the purchaser of the share is investing $1.02 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 259.74%.Revenue growth
The year-on-year revenue growth was 55%. We now have 2.59B in the 12 trailing months.
Moving Average
Jiayin Group is worth less than its moving average over 50 days of $2.25, and lower than its moving average over 200 days of $2.25.4. Wintrust Financial Corporation (WTFC)
24.2% sales growth and 10.25% return on equity
Wintrust Financial Corporation is a financial holding corporation. The company operates three divisions: Community Banking and Specialty Finance. It offers safe deposit facilities, home equity, consumer and real estate loans, as well as non-interest-bearing deposits and non-brokered, interest-bearing transactions accounts. The bank also offers residential mortgages to be purchased and originated by retail. It provides cash management, lending and deposits services for homeowners, condominiums, and other community organizations. This segment also offers mortgage broker companies loan and deposit services; loans to franchisees of restaurants; direct leasing; small-business administration loans; construction loans and commercial mortgages; as well as financial solutions. This bank provides commercial and personal banking services to small and medium-sized business owners, as well as local government units and institutions. Specialty Finance offers life and commercial insurance premiums financing to individuals and businesses; outsourced administration services and value-added financing; and data processing for payrolls and billing. Wealth Management provides services such as trust and investment and asset management. It operates 229 ATMs and 181 banks in Chicago, the Chicago metro area, southwest Indiana, Northwest Indiana and Florida. Wintrust Financial Corporation was established in 1991. It is located in Rosemont in Illinois.
Earnings Per Share
As for profitability, Wintrust Financial Corporation has a trailing twelve months EPS of $7.36.
PE Ratio
Wintrust Financial Corporation has a trailing twelve months price to earnings ratio of 10.9. Meaning, the purchaser of the share is investing $10.9 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.25%.Growth Estimates Quarters
The company's growth estimates for the ongoing quarter and the next is 63.3% and 24.6%, respectively.5. Tecnoglass (TGLS)
18.4% sales growth and 44.06% return on equity
Tecnoglass Inc., through its subsidiaries, manufactures, supplies, and installs architectural glass, windows, and associated aluminum products for the commercial and residential construction industries in North, Central, and South America. The company offers low emissivity, laminated/thermo-laminated, thermo-acoustic, tempered, silk-screened, curved, and digital print glass products. It also produces, exports, imports, and markets aluminum products, including bars, plates, profiles, rods, tubes, and other hardware that are used in the manufacture of architectural glass settings, such as windows, doors, spatial separators, and related products. In addition, the company provides curtain wall/floating facades, windows and doors, interior dividers and commercial display windows, hurricane-proof windows, stick facade systems, and other products, such as awnings, structures, automatic doors, and other components of architectural systems. It markets and sells its products primarily under the Tecnoglass, ES Windows, and Alutions brands through internal and independent sales representatives, as wells as directly to distributors. The company was founded in 1984 and is headquartered in Barranquilla, Colombia. Tecnoglass Inc. is a subsidiary of Energy Holding Corporation.
Earnings per Share
Tecnoglass' trailing 12 month EPS is $2.53.
PE Ratio
Tecnoglass' trailing 12-month price-to-earnings ratio is 12.38. The purchaser of the shares is therefore investing $12.38 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 44.06%.Earnings before Interest, Taxes and Depreciation
Tecnoglass has an EBITDA of 2.47.
Volume
The Tecnoglass last reported volume is 612012, which is 211.14% more than its average volume of 196695.
6. FVCBankcorp (FVCB)
18.3% sales growth and 13.34% return on equity
FVCBankcorp, Inc. is the holding company of FVCbank, which provides various services and products in Virginia. The company offers deposit products including checking and savings accounts and money market accounts. It also offers commercial real estate loans, commercial construction loans, commercial loans for different business purposes such as working capital, equipment purchase, lines of credit and financing for government contracts; SBA loans, asset-based loans, accounts receivable financing, home equity loans, and consumer loans. It also offers merchant services, business credit cards, business insurance, business banking and remote deposit services. It serves commercial and nonprofit businesses as well as professional services entities and their owners located in greater Washington, D.C., Baltimore, and surrounding areas. FVCBankcorp, Inc. is headquartered in Fairfax, Virginia. FVCBankcorp, Inc. also has 11 branch offices located in Arlington, Virginia, Ashburn, Loudoun County Virginia, and the independent city Manassas in Virginia. It also maintains a network in Reston, Fairfax County Virginia, Springfield, Fairfax County Virginia, and Montgomery County Maryland. There is also a loan production office located in Lutherville, Maryland. FVCBankcorp, Inc. is an American bank based in Fairfax, Virginia.
Earnings Per Share
As for profitability, FVCBankcorp has a trailing twelve months EPS of $1.79.
PE Ratio
FVCBankcorp has a trailing twelve months price to earnings ratio of 10.49. Meaning, the purchaser of the share is investing $10.49 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.34%.Yearly Top and Bottom Value
FVCBankcorp's stock is valued at $18.77 at 15:22 EST, way under its 52-week high of $21.90 and higher than its 52-week low of $18.00.
Volume
FVCBankcorp's current reported volume is 9740, which is 57% lower than its average volume at 23185.
Sales Growth
FVCBankcorp's sales growth is 18.1% for the ongoing quarter and 18.3% for the next.
7. Core Laboratories N.V. (CLB)
14.8% sales growth and 9.15% return on equity
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment offers services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amstelveen, the Netherlands.
Earnings per Share
Core Laboratories N.V.'s trailing twelve-month EPS is $0.42.
PE Ratio
Core Laboratories N.V.'s trailing 12 months earnings to price ratio is 46.48. The purchaser of the shares is therefore investing $46.48 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 9.15%.8. First Foundation (FFWM)
11.2% sales growth and 12.39% return on equity
First Foundation Inc., through its subsidiaries, provides personal banking, business banking, and private wealth management services in the United States. It operates through two segments, Banking and Wealth Management. The company offers a range of bank deposit products, including personal and business checking accounts, savings accounts, interest-bearing negotiable order of withdrawal accounts, money market accounts, and time certificate of deposits; and loan products consisting of multifamily and single family residential real estate loans, commercial real estate loans, and commercial term loans and line of credits, as well as consumer loans, such as personal installment loans and line of credits, and home equity line of credits. It also provides various specialized services comprising trust services, internet and mobile banking, remote deposit capture services, merchant credit card services, ATM cards, Visa debit cards, and business sweep accounts, as well as insurance brokerage services and equipment financing solutions. In addition, the company offers investment management and financial planning services; treasury management services; advisory and coordination services in the areas of estate planning, retirement planning, and charitable and business ownership issues; and financial, investment, and economic advisory and related services. Further, it provides support services, including the processing and transmission of financial and economic data for charitable organizations. The company operates through a network of 28 branch offices and 3 loan production offices in California, Nevada, Texas, and Hawaii. First Foundation Inc. was founded in 1985 and is headquartered in Dallas, Texas.
Earnings per Share
First Foundation's trailing 12 months profit per share (EPS) is $2.16
PE Ratio
First Foundation's trailing 12-month price-to-earnings ratio is 6.46. The purchaser of the shares is investing $6.46 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 12.39%.Volume
Today's last reported volume for First Foundation is 379969 which is 4.75% above its average volume of 362738.